Cargando…
Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma
CIC-DUX4 sarcoma (CDS) is a highly aggressive and metastatic small round type of predominantly pediatric sarcoma driven by a fusion oncoprotein comprising the transcriptional repressor Capicua (CIC) fused to the C-terminal transcriptional activation domain of DUX4. CDS rapidly develops resistance to...
Autores principales: | Bosnakovski, Darko, Ener, Elizabeth T., Cooper, Mark S., Gearhart, Micah D., Knights, Kevin A., Xu, Natalie C., Palumbo, Christian A., Toso, Erik A., Marsh, Graham P., Maple, Hannah J., Kyba, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511258/ https://www.ncbi.nlm.nih.gov/pubmed/34642317 http://dx.doi.org/10.1038/s41389-021-00357-4 |
Ejemplares similares
-
Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression
por: Bosnakovski, Darko, et al.
Publicado: (2018) -
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes
por: Choi, Si Ho, et al.
Publicado: (2016) -
Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models
por: Hendrickson, Peter G., et al.
Publicado: (2023) -
Expression of the CIC-DUX4 fusion oncoprotein mimics human CIC-rearranged sarcoma in genetically engineered mouse models
por: Hendrickson, Peter G., et al.
Publicado: (2023) -
Cardiac Tamponade as an Unusual Initial Clinical Manifestation of CIC-DUX4 Sarcoma
por: Maekawa, Akira, et al.
Publicado: (2021)